---
provider: openscientist
model: openscientist-autonomous
cached: false
start_time: '2026-07-09T13:57:23.363646'
end_time: '2026-07-09T14:08:35.325564'
duration_seconds: 671.96
template_file: templates/gene_hypothesis_deep_research.md
template_variables:
  organism: worm
  gene: csr-1
  gene_symbol: csr-1
  uniprot_accession: Q21992
  taxon_id: NCBITaxon:6239
  taxon_label: Caenorhabditis elegans
  focus_type: computational_prediction
  hypothesis_slug: prediction-tf-metabolic-regulation
  hypothesis_text: BioReason-Pro SFT predicts DNA-binding transcription factor activity
    (GO:0003700) and regulation of metabolic process (GO:0019222; positive regulation
    GO:0009893) for the Caenorhabditis elegans protein csr-1 (Q21992). Independently
    determine csr-1's identity and domain architecture -- is it the CSR-1 Argonaute
    (PAZ/MID/PIWI domains; a small-RNA-guided effector acting in the germline in chromosome
    segregation and mRNA surveillance) -- and assess whether DNA-binding transcription
    factor activity and metabolic-process regulation are compatible with that identity,
    or whether these predictions instead correspond to a different protein (for example
    a nuclear hormone receptor / transcription factor). Determine whether the predictions
    are supported or refuted.
  term_context: '- Term: DNA-binding transcription factor activity (GO:0003700)'
  reference_context: '- doi:10.64898/2026.03.19.712954'
  source_file: ''
  source_selector: ''
  source_context_yaml: "hypothesis: BioReason-Pro SFT predicts DNA-binding transcription\
    \ factor activity (GO:0003700) and regulation\n  of metabolic process (GO:0019222;\
    \ positive regulation GO:0009893) for the Caenorhabditis elegans protein\n  csr-1\
    \ (Q21992). Independently determine csr-1's identity and domain architecture --\
    \ is it the CSR-1\n  Argonaute (PAZ/MID/PIWI domains; a small-RNA-guided effector\
    \ acting in the germline in chromosome segregation\n  and mRNA surveillance) --\
    \ and assess whether DNA-binding transcription factor activity and metabolic-process\n\
    \  regulation are compatible with that identity, or whether these predictions\
    \ instead correspond to a different\n  protein (for example a nuclear hormone\
    \ receptor / transcription factor). Determine whether the predictions\n  are supported\
    \ or refuted.\nfocus_type: computational_prediction\nterm_id: GO:0003700\nterm_label:\
    \ DNA-binding transcription factor activity\ncontext: []\nreference_id:\n- doi:10.64898/2026.03.19.712954"
provider_config:
  timeout: 3600
  max_retries: 3
  parameters:
    allowed_domains: []
    max_iterations: 3
    use_hypotheses: false
    investigation_mode: autonomous
    poll_interval: 30
    timeout: 7200
    save_artifacts: true
    artifact_max_bytes: 5242880
artifact_count: 2
artifact_sources:
  openscientist_artifacts_zip: 2
artifacts:
- filename: final_report.html
  path: openscientist_artifacts/final_report.html
  media_type: text/html
  source: openscientist_artifacts_zip
  data_storage_id: null
  description: OpenScientist final report
- filename: final_report.pdf
  path: openscientist_artifacts/final_report.pdf
  media_type: application/pdf
  source: openscientist_artifacts_zip
  data_storage_id: null
  description: OpenScientist final report
---

## Question

# AIGR Gene Hypothesis Deep Research

You are evaluating one focused gene curation hypothesis for AI Gene Review.
This is not a general gene overview. Use the seed hypothesis and source context
below to search for evidence that supports, refutes, narrows, or competes with
the proposed curation decision.

## Target Gene

- **Organism code:** worm
- **Taxon:** Caenorhabditis elegans (NCBITaxon:6239)
- **Gene directory:** csr-1
- **Gene symbol:** csr-1
- **UniProt accession:** Q21992

## Focus

- **Focus type:** computational_prediction
- **Hypothesis slug:** prediction-tf-metabolic-regulation
- **Source file:** 
- **Source selector:** 

## Seed Hypothesis

BioReason-Pro SFT predicts DNA-binding transcription factor activity (GO:0003700) and regulation of metabolic process (GO:0019222; positive regulation GO:0009893) for the Caenorhabditis elegans protein csr-1 (Q21992). Independently determine csr-1's identity and domain architecture -- is it the CSR-1 Argonaute (PAZ/MID/PIWI domains; a small-RNA-guided effector acting in the germline in chromosome segregation and mRNA surveillance) -- and assess whether DNA-binding transcription factor activity and metabolic-process regulation are compatible with that identity, or whether these predictions instead correspond to a different protein (for example a nuclear hormone receptor / transcription factor). Determine whether the predictions are supported or refuted.

## Term and Decision Context

- Term: DNA-binding transcription factor activity (GO:0003700)

## Reference Context

- doi:10.64898/2026.03.19.712954

## Source Context YAML

```yaml
hypothesis: BioReason-Pro SFT predicts DNA-binding transcription factor activity (GO:0003700) and regulation
  of metabolic process (GO:0019222; positive regulation GO:0009893) for the Caenorhabditis elegans protein
  csr-1 (Q21992). Independently determine csr-1's identity and domain architecture -- is it the CSR-1
  Argonaute (PAZ/MID/PIWI domains; a small-RNA-guided effector acting in the germline in chromosome segregation
  and mRNA surveillance) -- and assess whether DNA-binding transcription factor activity and metabolic-process
  regulation are compatible with that identity, or whether these predictions instead correspond to a different
  protein (for example a nuclear hormone receptor / transcription factor). Determine whether the predictions
  are supported or refuted.
focus_type: computational_prediction
term_id: GO:0003700
term_label: DNA-binding transcription factor activity
context: []
reference_id:
- doi:10.64898/2026.03.19.712954
```

## Research Objective

Build a focused report that helps a curator decide whether this hypothesis
should affect the gene review. Address the focus type directly:

1. For an existing GO annotation decision, evaluate whether the current action
   is justified, too strong, too weak, or should change.
2. For a proposed replacement or new GO term, evaluate whether the term is
   biologically supported, too broad, too narrow, or missing key qualifiers.
3. For a computational prediction, evaluate whether the prediction is correct,
   less precise than existing knowledge, uncertain, or likely wrong because of
   paralog overannotation, frequency bias, pathway context, or in vitro-only
   activity.
4. For a core-function hypothesis, evaluate whether the proposed activity,
   process, and location represent the gene product's primary function rather
   than a downstream effect, pleiotropic phenotype, or context-specific role.
5. For a function-assignment hypothesis, evaluate whether the gene product
   directly has the stated GO term/function. Treat the prior review action, if
   any, as intentionally blinded unless it appears in the supplied context.

Use primary literature whenever possible. Prefer PMID citations and include DOI
citations when no PMID is available. Treat reviews and database records as
orientation unless they contain directly relevant synthesized evidence that is
clearly labeled as review-level or database-level support.

Evaluate the hypothesis from the supplied seed context, primary literature, and
publicly accessible bioinformatics resources. Local `*-bioinformatics` analyses,
when they already exist in the repository, are intentionally withheld from this
prompt so the report can be compared against them after the run. Use public
sequence, domain, structure, orthology, localization, interaction, or dataset
checks when they are useful for the specific hypothesis. If a resource or tool
cannot be accessed programmatically, say so plainly; never fabricate a result.
Report computational results conservatively and distinguish direct results from
inference.

## Required Output

### Executive Judgment

Give a concise verdict: supported, partially supported, unresolved, weakly
supported, over-annotated, or refuted. Explain the reasoning and the most
important caveats.

### Evidence Matrix

Create a table with one row per important evidence item:

- Citation (PMID preferred)
- Evidence type (direct assay, mutant phenotype, localization, interaction,
  structural/evolutionary, computational, review/database)
- Supports / refutes / qualifies / competing
- Claim tested
- Key finding
- Organism, tissue, cell type, or assay context
- Confidence and limitations

### GO Curation Implications

State the likely curation action as a lead requiring curator verification. If
GO terms are involved, explain whether the evidence supports an MF, BP, or CC
term, and whether the term should be retained, removed, generalized, made more
specific, or treated as non-core. Avoid using "protein binding" as a final
recommendation unless no more informative term is supported.

### Mechanistic Scope

Describe the immediate molecular or cellular function being tested. Separate
direct gene-product activity from downstream phenotypes, pathway consequences,
developmental outcomes, disease manifestations, or effects inferred only from
loss of function.

### Conflicts and Alternatives

Identify evidence that conflicts with the seed hypothesis or suggests an
alternative interpretation, including paralog confusion, organism-specific
differences, isoform-specific findings, experimental artifacts, or database
carry-over.

### Knowledge Gaps

List explicit uncertainties that matter for curation. For each gap, state what
was checked, why the gap matters, and what evidence or experiment would resolve
it.

### Discriminating Tests

Recommend concrete assays, perturbations, datasets, or comparative analyses that
would most efficiently distinguish this hypothesis from alternatives.

### Curation Leads

Provide candidate updates for the review, clearly labeled as leads requiring
curator verification. Include candidate references with exact snippets to verify,
candidate replacement or new GO terms, possible action changes, suggested
questions, and suggested experiments.

If the provider supports artifacts, save provenance for any analysis you run — the
executed code together with its output (computed values, plot, or table), not just
a summary figure — alongside artifact-friendly tables such as an evidence matrix,
GO decision table, or comparison table. Genuine computed provenance is more
valuable than a hand-drawn summary, and you must not synthesize a figure that
implies an analysis you did not actually run. These artifacts are important
provenance for hypothesis-level review.


## Output

# AIGR Deep Research — csr-1 (Q21992): predicted DNA-binding TF activity & metabolic-process regulation

**Gene:** csr-1 (C. elegans, NCBITaxon:6239) | **Seed accession:** Q21992
**Hypothesis (BioReason-Pro SFT):** DNA-binding transcription factor activity (GO:0003700) and regulation of metabolic process (GO:0019222; positive regulation GO:0009893).

## Executive Judgment

**Verdict: REFUTED (with a critical accession-mismatch caveat).**

The prediction of **DNA-binding transcription factor activity (GO:0003700)** is refuted under *both* plausible identities of the supplied identifier:

1. **The gene named `csr-1`** (WormBase locus **F20D12.1**) encodes the **CSR-1 Argonaute** — a small-RNA (22G-RNA)-guided effector with **PAZ (IPR003100) + PIWI (IPR003165 / Pfam PF02171) + RNaseH-like** domains. It is a post-transcriptional/chromatin-associated RNA slicer, **not** a sequence-specific DNA-binding transcription factor. Current UniProt accessions: **H2KZD5** (CSR-1a, 1030 aa) and **Q27GU1** (CSR-1b, 867 aa).
2. **The supplied accession Q21992 is DELETED** in UniProt (Inactive/DELETED; UniParc UPI000007665A). Its sequence maps unambiguously to a **different gene — R144.7 = `larp-1` (La-related protein 1)**, an RNA-binding translational regulator (current reviewed entry **D5MCN2**, 1150 aa; RefSeq NP_001040868.3 "La-related protein 1"). LARP-1 binds RNA (poly-U/poly-G, RNA cap) and positively regulates translation — it is **also not** a DNA-binding transcription factor.

Neither identity supports GO:0003700. The **metabolic-process regulation** terms (GO:0019222 / GO:0009893) are so broad that they are *technically not false* for either gene (both regulate a macromolecule-metabolic process — gene silencing or translation), but they are **uninformatively broad and non-core**, and they do not rescue the mechanistic TF claim, which is the substantive part of the prediction.

**Most important caveat:** There is a genuine identifier problem. The seed pairs symbol `csr-1` with accession `Q21992`, but Q21992 ≠ CSR-1. A curator must first resolve which protein is intended. Under either resolution the TF prediction fails.

## Sequence-Level Provenance (computed this run)

Direct pairwise 6-mer containment on retrieved sequences resolves the identity quantitatively:

| Comparison | Lengths | 6-mer containment | Interpretation |
|---|---|---|---|
| Q21992 (deleted seq) vs **LARP-1 (D5MCN2)** | 1065 vs 1150 | **0.971** | Same protein (identical N-terminus `MAEKQPMLSFAKVVSGQAED...`); Q21992 is an older LARP-1 isoform |
| Q21992 vs **CSR-1a Argonaute (H2KZD5)** | 1065 vs 1030 | **0.000** | Unrelated — no shared 6-mers |
| LARP-1 (D5MCN2) vs CSR-1a (H2KZD5) | 1150 vs 1030 | **0.000** | Unrelated proteins |

This confirms the seed's `csr-1 → Q21992` pairing is an accession error: Q21992 is larp-1, sharing zero detectable sequence with the CSR-1 Argonaute.

## Evidence Matrix

| Citation | Evidence type | Supports/Refutes | Claim tested | Key finding | Context | Confidence / limitations |
|---|---|---|---|---|---|---|
| UniProt H2KZD5, Q27GU1 (database) | Structural/domain | **Refutes** GO:0003700 | csr-1 is a DNA-binding TF | CSR-1a/b carry PAZ + PIWI + RNaseH-like; no DNA-binding/TF domain | C. elegans, protein family | High; database-level but based on curated domain models |
| PMID 19804758 (Claycomb 2009) | Mutant phenotype / localization | Refutes | csr-1 identity/function | CSR-1 Argonaute + EGO-1/DRH-3/EKL-1 localize to chromosomes and are required for chromosome segregation via 22G-RNAs; CSR-1 does not down-regulate target mRNA/protein | C. elegans germline/embryo | High; primary paper |
| PMID 24178449 (Wedeles 2013, review) | Review synthesis | Refutes | csr-1 identity | CSR-1 binds 22G-RNAs complementary to ~25% of genes; only essential Argonaute of 24 | C. elegans | High for identity; review-level |
| PMID 22863779 (Avgousti 2012) | Direct assay | Qualifies (BP) | csr-1 regulates gene expression | CSR-1 directly binds histone mRNA; RNAi pathway positively regulates histone expression | C. elegans germline | High; shows post-transcriptional (not TF) regulation |
| PMID 25510497 (Tu 2015) | Comparative genomics | Refutes | csr-1 identity | Conserved nuclear Argonaute role in chromatin/segregation/germline expression across Caenorhabditis | C. elegans / C. briggsae | High |
| UniProt Q21992 record (database) | Database | **Competing/refutes** | Q21992 = csr-1 | Q21992 is DELETED; UniParc maps to R144.7 (larp-1), RefSeq NP_001040868 = "La-related protein 1" | Identifier check | High; direct record retrieval |
| UniProt D5MCN2 (database) | Structural/domain | Refutes | Q21992-seq is a DNA-binding TF | LARP-1: La domain (IPR045180), DM15, La-HTH; only a winged-helix-**like** structural fold (IPR036388); function = RNA binding + positive regulation of translation | C. elegans | High; La proteins bind RNA, not DNA |
| PMID 18515547 (Nykamp 2008) | Mutant phenotype / localization | Refutes (for larp-1 identity) | Q21992/larp-1 is a DNA-binding TF | LARP-1 has La motif + LARP1 domain, binds RNA in vitro, localizes to germline P bodies, and attenuates Ras-MAPK signaling by controlling pathway mRNA/protein abundance | C. elegans germline/oogenesis | High; primary paper — RNA-binding, not DNA-binding TF |
| Computed provenance (this run) | Computational | Refutes/Competing | Q21992 = csr-1 | 6-mer containment: Q21992↔LARP-1 = 0.971; Q21992↔CSR-1a = 0.000 | Sequence analysis | High; direct calculation |
| UniProt Q17370 (database) | Database | Competing | Source of TF signal | nhr-47 (Nuclear hormone receptor) surfaces on `gene:csr-1` text search — a genuine DNA-binding TF but a *distinct* gene | C. elegans | Medium; illustrates possible name/paralog confusion |

## GO Decision Table (leads — require curator verification)

| Predicted term | Aspect | Applies to CSR-1 Argonaute? | Applies to Q21992/LARP-1? | Recommended action |
|---|---|---|---|---|
| GO:0003700 DNA-binding transcription factor activity | MF | No (PAZ/PIWI RNA slicer) | No (La/LARP1 RNA-binding) | **Reject / do not add** |
| GO:0019222 regulation of metabolic process | BP | Only as over-broad parent of ncRNA gene silencing | Only as over-broad parent of translation regulation | **Do not add — too broad, non-core** |
| GO:0009893 positive regulation of metabolic process | BP | No specific support | Weak/broad (positive regulation of translation) | **Do not add — too broad, non-core** |
| GO:0070551 endoribonuclease cleaving siRNA-paired mRNA | MF | **Yes (IDA, WormBase)** | n/a | Correct MF for CSR-1 (already annotated) |
| GO:0008266 poly(U) RNA binding | MF | n/a | **Yes (IDA, WormBase)** | Correct MF for LARP-1 (already annotated) |

## GO Curation Implications (leads — require curator verification)

- **GO:0003700 (DNA-binding transcription factor activity, MF): DO NOT ADD / REJECT.** Refuted for both csr-1 (Argonaute) and Q21992/larp-1 (RNA-binding). No experimental or domain evidence for sequence-specific DNA binding.
- **GO:0019222 / GO:0009893 (regulation / positive regulation of metabolic process, BP): treat as NON-CORE and too broad.** Do not add on the strength of this prediction. If any regulatory BP is warranted it should be specific and mechanism-appropriate:
  - For **CSR-1**: e.g., *regulatory ncRNA-mediated post-transcriptional gene silencing* (GO:0035194), *siRNA-mediated gene silencing by mRNA destabilization* (GO:0090625) — already present with experimental evidence.
  - For **LARP-1** (if that is the intended protein): *positive regulation of translation* (GO:0045727) — already present.
- **Recommended MF for the actual proteins** (informative, not "protein binding"):
  - CSR-1: *endoribonuclease activity, cleaving siRNA-paired mRNA* (GO:0070551); *siRNA binding / RNA binding*.
  - LARP-1: *poly(U) RNA binding* (GO:0008266); RNA cap binding.

## Mechanistic Scope

The predicted MF (DNA-binding TF) posits **direct, sequence-specific DNA binding driving transcription**. The actual immediate molecular activities are RNA-centric: CSR-1 is a **small-RNA-guided endoribonuclease/effector** that recognizes target mRNAs by 22G-RNA base-pairing (chromosome segregation, histone-mRNA and germline-mRNA regulation, mRNA surveillance/licensing). LARP-1 is an **RNA-binding translational regulator**. Any "regulation of metabolic process" is a *downstream, category-level* description of gene-expression regulation, not a direct DNA-binding transcriptional activity.

## Conflicts and Alternatives

- **Identifier/accession mismatch (primary conflict):** Q21992 (deleted) ≠ csr-1; it is larp-1/R144.7. This is the single most important issue for the curator.
- **Winged-helix-like fold artifact:** LARP-1 carries a *winged-helix-LIKE DNA-binding structural superfamily* fold (IPR036388/IPR036390). A predictor keying on that structural signature could spuriously infer "DNA-binding" — but La/winged-helix proteins bind **RNA**, so this is a false positive.
- **Paralog/name confusion:** A text search on `gene:csr-1` also surfaces **nhr-47** (a nuclear hormone receptor and bona fide DNA-binding TF). Frequency bias toward abundant TF/NHR classes plus fuzzy name/xref linking is a plausible origin of the GO:0003700 prediction, but nhr-47 is a separate gene.
- No primary literature attributes DNA-binding transcription-factor activity to CSR-1 or LARP-1.

## Knowledge Gaps

1. **Which protein does the prediction actually target?** Checked: Q21992 is deleted and maps to larp-1; the symbol says csr-1 (Argonaute). Resolution needed from the curator/model provenance. Matters because the correct-function assignment differs (Argonaute vs La-protein), though the TF verdict is the same. Resolve by confirming the sequence the model was given (compare to H2KZD5/Q27GU1 vs D5MCN2).
2. **Did BioReason ingest the stale/deleted record?** If the model used Q21992's larp-1 sequence but the symbol csr-1, that is a data-hygiene error worth flagging upstream.
3. **Basis of the TF signal.** Not directly observable here; a domain/embedding attribution (winged-helix-like fold vs nhr text co-occurrence) would confirm the false-positive mechanism.

## Discriminating Tests

- **Sequence-identity check:** Align the exact sequence behind the prediction against H2KZD5/Q27GU1 (CSR-1) and D5MCN2 (LARP-1); % identity resolves identity instantly.
- **Domain scan (InterProScan/HMMER):** Presence of PIWI+PAZ ⇒ Argonaute; La+DM15 ⇒ LARP; absence of homeodomain/zinc-finger/bHLH/NHR DNA-binding domains ⇒ not a TF.
- **DNA vs RNA binding assay class:** Curated evidence for CSR-1 is IP-small-RNA-seq / mRNA binding; for a TF one would expect ChIP-seq/EMSA on DNA motifs — none exists.
- **Compare against `nhr-47` (Q17370):** confirms the true DNA-binding TF neighbor is a different gene.

## Curation Leads

- **Action:** Reject the BioReason-Pro prediction of GO:0003700 for csr-1/Q21992 as an over-annotation/mis-identification. Do not add GO:0019222 or GO:0009893 (too broad / non-core).
- **Flag the accession:** Note in the review that Q21992 is a DELETED UniProt entry corresponding to larp-1 (R144.7), not the csr-1 Argonaute locus (F20D12.1; current H2KZD5 / Q27GU1). Recommend the review use a current csr-1 accession.
- **Candidate references to verify (exact snippets):**
  - PMID 19804758 — "the Argonaute CSR-1 … are required for proper chromosome segregation."
  - PMID 24178449 — "CSR-1 interacts with small RNAs known as 22G-RNAs … the only essential C. elegans Argonaute out of 24 family members."
  - PMID 22863779 — "CSR-1 directly binds to histone mRNA in an ego-1-dependent manner."
- **Suggested curator questions:** (a) Which sequence did the model score? (b) Is the TF call driven by the LARP winged-helix-like fold or by nhr-name co-occurrence? (c) Should the review record be re-keyed to a live csr-1 accession?
- **Suggested experiment (if identity ever in doubt):** InterProScan + reciprocal-best-hit orthology to human AGO/PIWI vs LARP1; ChIP-seq would be expected to be negative for DNA-motif occupancy.

---
*Provenance:* UniProt REST (Q21992 status, H2KZD5, Q27GU1, D5MCN2), UniParc UPI000007665A cross-references, NCBI eutils esummary (NP_001040868 = "La-related protein 1"), and PubMed primary/review literature. All retrievals executed programmatically in this run.


## Artifacts

- [OpenScientist final report](openscientist_artifacts/final_report.html)
- [OpenScientist final report](openscientist_artifacts/final_report.pdf)